Literature DB >> 6203351

The interaction of cholinomimetics, peptides and compounds 48/80 on histamine secretion from the mast cell.

F Erjavec, M Iskra.   

Abstract

The mechanism of selective, non-immunological histamine release from mast cells, caused by various endogenous substances, is not clearly understood. Since in vivo experiments indicate that the local control of secretory cells is influenced by acetylcholine and peptides, we investigated whether the secretion of histamine is similarly regulated in the mast cell. Experiments were performed with peritoneal cavity cell suspensions (PCS) of the rat. The endogenous polypeptide substance P, compound 48/80 and a non-hydrolysable cholinomimetic agonist, carbachol, were used. The concentrations of the drugs were kept low to avoid non-specific histamine release caused by morphological damage of mast cells. It was found that: (1) carbachol (2 X 10(-5) M) did not release histamine from PCS, (2) substance P (6.5 X 10(-6) M) released histamine and this effect was increased by the addition of carbachol (2 X 10(-5) M); the effect of carbachol was inhibited by atropine , (3) carbachol (2 X 10(-5)M) did not increase histamine release caused by compound 48/80 (0.02 micrograms/ml). From these experiments it may be concluded that activation of peptidergic receptor(s) can cause histamine release from mast cells and that muscarinic agents may be involved in the regulation of the(se) receptor(s).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6203351     DOI: 10.1007/bf01973831

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  16 in total

1.  Release of histamine by substance P.

Authors:  F Erjavec; F Lembeck; T Florjanc-Irman; G Skofitsch; J Donnerer; A Saria; P Holzer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-08       Impact factor: 3.000

2.  Histamine release from mast cells by physiologically occurring substances.

Authors:  F Erjavec
Journal:  Agents Actions       Date:  1981-04

Review 3.  Modulation of the spontaneous histamine release by adrenergic and cholinergic drugs.

Authors:  R Fantozzi; F Moroni; E Masini; P Blandina; P F Mannaioni
Journal:  Agents Actions       Date:  1978-06

4.  The role of the N-terminal tetrapeptide in the histamine releasing action of substance P.

Authors:  N Mazurek; I Pecht; V I Teichberg; S Blumberg
Journal:  Neuropharmacology       Date:  1981-11       Impact factor: 5.250

5.  Histamine-releasing effect of a corticotrophin derivative. I. Histamine-releasing effect of a nonadecapeptide in comparison with that of other histamine liberators.

Authors:  M Rüegg; R Jaques
Journal:  Pharmacology       Date:  1977       Impact factor: 2.547

6.  Evidence for a carbachol stimulated phosphatidylinositol effect in heart.

Authors:  E E Quist
Journal:  Biochem Pharmacol       Date:  1982-10-01       Impact factor: 5.858

7.  Mast cell histamine secretion in response to somatostatin analogues: structural considerations.

Authors:  T C Theoharides; W W Douglas
Journal:  Eur J Pharmacol       Date:  1981-07-17       Impact factor: 4.432

8.  Histamine release by vagal stimulation.

Authors:  P Blandina; M Barattini; R Fantozzi; E Masini; P F Mannaioni
Journal:  Agents Actions       Date:  1983-04

9.  The effects of substance P on histamine and 5-hydroxytryptamine release in the rat.

Authors:  C M Fewtrell; J C Foreman; C C Jordan; P Oehme; H Renner; J M Stewart
Journal:  J Physiol       Date:  1982-09       Impact factor: 5.182

10.  Mast cell degranulation, hepatic glycogen depletion, and hyperglycemia in Compound 48/80 or pilocarpine-treated rats.

Authors:  R V Dimlich; S F Townsend; F D Reilly
Journal:  Hepatology       Date:  1982 May-Jun       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.